Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Alumis Inc. | 0 | 1,959,896 | +1,959,896 | 0 | 26,067 | 8.16% | +26,067 |
| enGene Holdings Inc. COM | 0 | 500,000 | +500,000 | 0 | 4,715 | 1.48% | +4,715 |
| KALA Bio, Inc.(KALA) | 0 | 443,661 | +443,661 | 0 | 3,146 | 0.98% | +3,146 |
| Mineralys Therapeutics Inc.(MLYS) | 2,016,822 | 2,016,822 | 0 | 26,037 | 23,597 | 7.39% | -2,440 |
| Design Therapeutics, Inc.(DSGN) | 6,526,476 | 6,526,476 | 0 | 26,302 | 21,864 | 6.85% | -4,438 |
| ARS Pharmaceuticals, Inc.(SPRY) | 4,012,903 | 4,012,903 | 0 | 41,012 | 34,150 | 10.69% | -6,862 |
| CRISPR Therapeutics AG(CRSP) | 1,048,951 | 1,048,951 | 0 | 71,497 | 56,654 | 17.74% | -14,843 |
| Nkarta, Inc.(NKTX) | 3,333,333 | 3,333,333 | 0 | 36,033 | 19,700 | 6.17% | -16,333 |
| Arcellx, Inc. COMMON STOCK | 2,346,630 | 2,346,630 | 0 | 163,208 | 129,511 | 40.55% | -33,698 |